126 related articles for article (PubMed ID: 35545856)
1. Suitability of NIID-MDCK cells as a substrate for cell-based influenza vaccine development from the perspective of adventitious virus susceptibility.
Hamamoto I; Takahashi H; Shimasaki N; Nakamura K; Mizuta K; Sato K; Nishimura H; Yamamoto N; Hasegawa H; Odagiri T; Tashiro M; Nobusawa E
Microbiol Immunol; 2022 Jul; 66(7):361-370. PubMed ID: 35545856
[TBL] [Abstract][Full Text] [Related]
2. Comparison of suspension MDCK cells, adherent MDCK cells, and LLC-MK2 cells for selective isolation of influenza viruses to be used as vaccine seeds.
Harada Y; Takahashi H; Trusheim H; Roth B; Mizuta K; Hirata-Saito A; Ogane T; Odagiri T; Tashiro M; Yamamoto N
Influenza Other Respir Viruses; 2020 Mar; 14(2):204-209. PubMed ID: 31651085
[TBL] [Abstract][Full Text] [Related]
3. Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines.
Shin D; Park KJ; Lee H; Cho EY; Kim MS; Hwang MH; Kim SI; Ahn DH
Virus Res; 2015 Jun; 204():40-6. PubMed ID: 25892718
[TBL] [Abstract][Full Text] [Related]
4. Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells.
Suzuki Y; Odagiri T; Tashiro M; Nobusawa E
PLoS One; 2016; 11(7):e0160040. PubMed ID: 27454606
[TBL] [Abstract][Full Text] [Related]
5. Isolation of influenza viruses in MDCK 33016PF cells and clearance of contaminating respiratory viruses.
Roth B; Mohr H; Enders M; Garten W; Gregersen JP
Vaccine; 2012 Jan; 30(3):517-22. PubMed ID: 22119922
[TBL] [Abstract][Full Text] [Related]
6. High yield production of influenza virus in Madin Darby canine kidney (MDCK) cells with stable knockdown of IRF7.
Hamamoto I; Takaku H; Tashiro M; Yamamoto N
PLoS One; 2013; 8(3):e59892. PubMed ID: 23555825
[TBL] [Abstract][Full Text] [Related]
7. Systematic evaluation of suspension MDCK cells, adherent MDCK cells, and LLC-MK2 cells for preparing influenza vaccine seed virus.
Nakamura K; Harada Y; Takahashi H; Trusheim H; Bernhard R; Hamamoto I; Hirata-Saito A; Ogane T; Mizuta K; Konomi N; Konomi Y; Asanuma H; Odagiri T; Tashiro M; Yamamoto N
Vaccine; 2019 Oct; 37(43):6526-6534. PubMed ID: 31500967
[TBL] [Abstract][Full Text] [Related]
8. Performance characteristics of qualified cell lines for isolation and propagation of influenza viruses for vaccine manufacturing.
Donis RO; ; Davis CT; Foust A; Hossain MJ; Johnson A; Klimov A; Loughlin R; Xu X; Tsai T; Blayer S; Trusheim H; Colegate T; Fox J; Taylor B; Hussain A; Barr I; Baas C; Louwerens J; Geuns E; Lee MS; Venhuizen O; Neumeier E; Ziegler T
Vaccine; 2014 Nov; 32(48):6583-90. PubMed ID: 24975811
[TBL] [Abstract][Full Text] [Related]
9. Plaque purification as a method to mitigate the risk of adventitious-agent contamination in influenza vaccine virus seeds.
Murata H; Macauley J; Lewis AM; Peden K
Vaccine; 2011 Apr; 29(17):3155-61. PubMed ID: 21354480
[TBL] [Abstract][Full Text] [Related]
10. Generation of a High-Growth Influenza Vaccine Strain in MDCK Cells for Vaccine Preparedness.
Kim EH; Kwon HI; Park SJ; Kim YI; Si YJ; Lee IW; Kim SM; Kim SI; Ahn DH; Choi YK
J Microbiol Biotechnol; 2018 Jun; 28(6):997-1006. PubMed ID: 29642288
[TBL] [Abstract][Full Text] [Related]
11. CACO-2 cells: A continuous cell line with sensitive and broad-spectrum utility for respiratory virus culture.
Ramani R; Laplante JM; Church TM; Farrell GM; Lamson DM; St George K
J Virol Methods; 2021 Jul; 293():114120. PubMed ID: 33676967
[TBL] [Abstract][Full Text] [Related]
12. Comparison of different tissue cultures for isolation and quantitation of influenza and parainfluenza viruses.
Frank AL; Couch RB; Griffis CA; Baxter BD
J Clin Microbiol; 1979 Jul; 10(1):32-6. PubMed ID: 227920
[TBL] [Abstract][Full Text] [Related]
13. Comparative Susceptibility of Madin-Darby Canine Kidney (MDCK) Derived Cell Lines for Isolation of Swine Origin Influenza A Viruses from Different Clinical Specimens.
Suderman M; Moniwa M; Alkie TN; Ojkic D; Broes A; Pople N; Berhane Y
Viruses; 2021 Nov; 13(12):. PubMed ID: 34960614
[TBL] [Abstract][Full Text] [Related]
14. A Single-Step Method for Harvesting Influenza Viral Particles from MDCK Cell Culture Supernatant with High Yield and Effective Impurity Removal.
Liu S; Li J; Cheng Q; Duan K; Wang Z; Yan S; Tian S; Wang H; Wu S; Lei X; Yang Y; Ma N
Viruses; 2024 May; 16(5):. PubMed ID: 38793649
[TBL] [Abstract][Full Text] [Related]
15. Development of high-growth influenza H7N9 prepandemic candidate vaccine viruses in suspension MDCK cells.
Tzeng TT; Chen PL; Weng TC; Tsai SY; Lai CC; Chou HI; Chen PW; Lu CC; Liu MT; Sung WC; Lee MS; Hu AY
J Biomed Sci; 2020 Apr; 27(1):47. PubMed ID: 32241276
[TBL] [Abstract][Full Text] [Related]
16. A risk-assessment model to rate the occurrence and relevance of adventitious agents in the production of influenza vaccines.
Gregersen JP
Vaccine; 2008 Jun; 26(26):3297-304. PubMed ID: 18468737
[TBL] [Abstract][Full Text] [Related]
17. A quantitative risk assessment of exposure to adventitious agents in a cell culture-derived subunit influenza vaccine.
Gregersen JP
Vaccine; 2008 Jun; 26(26):3332-40. PubMed ID: 18485545
[TBL] [Abstract][Full Text] [Related]
18.
Mayuramart O; Poomipak W; Rattanaburi S; Khongnomnan K; Anuntakarun S; Saengchoowong S; Chavalit T; Chantaravisoot N; Payungporn S
PeerJ; 2022; 10():e13989. PubMed ID: 36164603
[TBL] [Abstract][Full Text] [Related]
19. A Y161F Hemagglutinin Substitution Increases Thermostability and Improves Yields of 2009 H1N1 Influenza A Virus in Cells.
Wen F; Li L; Zhao N; Chiang MJ; Xie H; Cooley J; Webby R; Wang PG; Wan XF
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118117
[TBL] [Abstract][Full Text] [Related]
20. MDCK-SIAT1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells.
Oh DY; Barr IG; Mosse JA; Laurie KL
J Clin Microbiol; 2008 Jul; 46(7):2189-94. PubMed ID: 18480230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
